The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Heme Oxygenase-1 in Tumor Biology and Therapy
Abstract
Heme oxygenase-1 (HO-1) degrades heme to carbon monoxide (CO), biliverdin, and ferrous iron. As HO-1 expression is highly increased by stressful conditions, the major role of the enzyme is the protection against oxidative injury. Additionally, it regulates cell proliferation, modulates inflammatory response and facilitates angiogenesis. Beneficial activities of HO-1 have been recognized in many pathological states e.g. atherosclerosis, diabetes, ischemia/reperfusion injury or organ transplantation. Interestingly HO-1 expression is very often boosted in tumor tissues and could be further elevated in response to radio-, chemo-, or photodynamic therapy. A growing body of evidence suggests that HO-1 may play a role in tumor induction and can potently improve the growth and spread of tumors. This review discusses the implications of HO-1 properties for tumor proliferation and cell death, differentiation, angiogenesis and metastasis, and tumor-related inflammation. Finally, it suggests that pharmacological agents that regulate HO activity or HO-1 gene silencing may become powerful tools for preventing the onset or progression of various cancers and sensitize them to anticancer therapies. Keywords: Heme oxygenase-1, carcinogenesis, oxidative stress, cytoprotection, angiogenesis, metastasis, carbon monoxide (CO), biliverdin, ferrous iron, oxidative injury, atherosclerosis, diabetes, ischemia/reperfusion injury, photodynamic therapy, anticancer therapies, aneuploidy, malignancy, heterozygosity, serine/threonine kinases, Oncogenes, Tumor-associated angiogenic factors, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), reactive oxygen species (ROS), cytotoxicity, apoptotic/necrotic cell death, superoxide dismutase (SOD), biliverdin reductase (BvR), glucoronidated, UDPglucuronyl transferase, Purkinje cells, cerebellum, ferriporphyrins, ferrohemoglobin, hemopexin, haptoglobin, soluble guanylyl cyclase (sGC), tumor necrosis factor (TNF), interleukin-1β (IL-1β), macrophage inflammatory protein-1β (MIP-1β), lymphosarcoma, Kaposi sarcoma, viral G protein-coupled receptor (vGPCR), namely a-fetoprotein (AFP), Wilm's tumor protein-1 (WT-1), hepatocarcinogenesis, Squamous carcinoma, human gliomas, hormonerefractory prostate cancer (HRPCA), localized prostate cancer (PCA), activator protein-1 (AP-1), TUMOR CELL PROLIFERATION, mesoporphyrin-IX, cobalt protoporphyrin-IX (CoPPIX), cyclin-dependent kinase (Cdk), 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK), Sp1 (Stimulatory protein-1), vascular smooth muscle cells (VSMC), retinoblastoma protein (Rb), desferroxamine (DFO), mesenchymal stem cells (MSC), dimethyl sulfoxide (DMSO), haematopoietic, endothelial progenitor cells (EPC), APOPTOSIS, ZnPPIX-poly ZnPPIX-polyethylene, glycol (ZnPPIX-PEG), epigallocatechin 3-gallate (EGCG), anticancerogenic polyphenol, iron regulatory proteins (IRP1, transferrin receptor (TfR), astroglia, myelogenous leukemia cells, keratinocytes, matrix metalloproteinase-1 (MMP-1), thymidyne phosphorylase (TP), stroma cell-derived growth factor-1 (SDF-1), splenomegaly, lymphadenopathy, lipopolysaccharide (LPS), c-Jun N-terminal kinase, colony, –, stimulating factor (GMCSF), toll-like receptor-4 (TLR4), oral squamous cell carcinoma (OSCC), tin mesoporphyrin-IX (SnMPIX, telomerase reverse transcriptase (TERT)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HO exists in two izoforms, significantly different in their regulatory mechanism: HO-1 is an inducible form whereas HO-2 is expressed constitutively [27,28].”
From Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer (2011) · cites this paper as [28]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty-Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 257
RetractedRegulation of IL-1β-induced GM-CSF production in human airway smooth muscle cells by carbon monoxide
Song, R., Ning, W., Liu, F., Ameredes, B. T., Calhoun, W. J., Otterbein, L. E., & Choi, A. M. K. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00212.2002 · Cited by 42
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 2×
“[252] Mantovani A, Sozzani S, Locati M, Allavena P, Sica A.”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 2×
“[11] Karin M.”
BackgroundAsahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 2,948
Cited by
Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A., & Dulak, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2223-0 · Cited by 2,632
Self-citationOxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
“There is a low expression of HO-1 at baseline in nearly all cells, but it is strongly induced by its substrate heme, heat shock, UV radiation, I/R injury, lipopolysaccharide (LPS), cytokines, and oxidative stress (312).”
BackgroundMetabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
Suda, T., Takubo, K., & Semenza, G. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.09.010 · Cited by 844
Gasotransmitters in cancer: from pathophysiology to experimental therapy
Szabo, C. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.1 · Cited by 717
Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth
Wegiel, B., Gallo, D., Csizmadia, E., Harris, C., Belcher, J., Vercellotti, G. M., Penacho, N., Seth, P., Sukhatme, V., Ahmed, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1075 · Cited by 376
Metadata
- Authors
- Was, H., Dulak, J., & Jozkowicz, A.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-12-01
- Volume
- 11
- Issue
- 12
- Pages
- 1551-1570
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2142595050
- Cited by
- 259
- References
- 297
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 11 · 2023: 3 · 2022: 14 · 2021: 18 · 2020: 12 · 2019: 12 · 2018: 18 · 2017: 20 · 2016: 23 · 2015: 34 · 2014: 25 · 2013: 17 · 2012: 20
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- heme oxygenase-1, cancer, oxidative stress, angiogenesis, metastasis, tumor inflammation, carbon monoxide, biliverdin, ferrous iron, carcinogenesis, cancer therapy, photodynamic therapy, apoptosis, reactive oxygen species, cell proliferation, cell death, gene silencing, hepatocarcinogenesis, glioma, Kaposi's sarcoma
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Cell Differentiation, Enzyme Induction, Humans, Inflammation, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Polymorphism, Genetic, Precancerous Conditions, Gene Expression Regulation, Neoplastic, Apoptosis, Oxidative Stress, Cell Proliferation, Heme Oxygenase-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heme Oxygenase-1 in Tumor Biology and Therapy. https://app.cochat.ai/papers/10.2174/1389450111009011551
- The paper
- Was, H., Dulak, J., & Jozkowicz, A. (2010). Heme Oxygenase-1 in Tumor Biology and Therapy. Current Drug Targets. https://doi.org/10.2174/1389450111009011551
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.